Tag: Prescription Drugs
β-Blockers May Up Risk of Surgical Complications for Some
Heightened risks of cardiovascular complications seen during non-cardiac surgeries
Add-On Sitagliptin Cuts Risk of Insulin Initiation in T2DM
Risk of insulin initiation lower for sitagliptin versus sulphonylurea as add-on to metformin
FDA Approves New Combo Therapy for Melanoma
Yervoy and Opdivo previously approved individually to treat melanoma
Two Experimental Drugs Promising for Psoriasis Rx
Targeted therapies produce significant results, researchers say
Long Duration Dual Antiplatelet Treatment Increases Bleeding
However, leads to small decrease in stent thrombosis, myocardial infarction after stent
Angioedema Induced by New Classes of Drugs
Angioedema occurs with DPP IV or neprilysin blockers; bradykinin contribution seems likely
New Treatment Option for Some With Metastatic Lung Cancer
Nivolumab found most effective in tumors expressing programmed death-ligand 1
β-Blocker Dose More Impactful Than Heart Rate in Heart Failure
BB dose has greater impact than lower heart rate in patients with heart failure from HF-ACTION trial
Novel Immunotx Shows Promise Against Advanced Renal Cancer
Nivolumab appears to outperform everolimus in new clinical trial
Spironolactone Seems Effective for Female Pattern Hair Loss
Patients with acne or hirsutism show significantly better response to spironolactone
